|
|||||
|
|

Industrial manufacturer Standex (NYSE:SXI) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 27.6% year on year to $217.4 million. Its non-GAAP profit of $1.99 per share was 4.4% above analysts’ consensus estimates.
Is now the time to buy SXI? Find out in our full research report (it’s free for active Edge members).
Standex’s third quarter results for 2025 came in above Wall Street’s expectations for both revenue and adjusted earnings per share, but the market responded negatively, with the stock declining after the announcement. Management pointed to robust growth from newly launched products and continued expansion in fast-growth markets as key drivers. CEO David Dunbar highlighted a record order intake and strong performance from the recently acquired Standex Electronics Grid business, but also acknowledged that organic growth in the core electronics segment was challenged by customer project delays and a facility closure.
Looking ahead, Standex’s outlook is shaped by ongoing investments in growth, a ramp-up in new product launches, and the scaling of its grid modernization platforms. Management expects the company’s expanded presence in Croatia and Mexico to support rising demand in Europe and the Americas, particularly across data centers and electrification projects. CFO Ademir Sarcevic noted, however, that margin improvements will be partially offset by increased spending on growth initiatives and less favorable product mix, with Dunbar stating, “We remain on track to achieve our long-term targets, but are mindful of potential disruptions in global trade and tariffs.”
Management emphasized that acquisitions, new product launches, and expansion into fast-growth markets were central to the quarter’s performance, while cost controls and restructuring in legacy segments provided additional support.
Standex’s near-term outlook is driven by continued investment in new product development, geographic expansion, and leveraging its acquisition pipeline, but faces headwinds from growth spending and product mix shifts.
In the coming quarters, our analysts will be tracking (1) the pace and success of new product launches, (2) ramp-up and utilization of the new Croatia and Mexico facilities to meet regional demand, and (3) cost savings materializing from recent restructuring in the Engraving segment. We’ll also watch for signs of recovery in Scientific and Specialty Solutions as funding and demand trends evolve.
Standex currently trades at $233.23, down from $239.11 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free for active Edge members).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| 8 hours | |
| Nov-03 | |
| Nov-03 | |
| Oct-31 | |
| Oct-31 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-30 | |
| Oct-28 | |
| Oct-24 | |
| Oct-23 | |
| Oct-22 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite